Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 10001-10050 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05566782
Cross-sectoral Rehabilitation After Stroke (CRES)
N/A
Active, not recruiting
117 participants
Started: Jan 23, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05214482
A Study of AK112 in Advanced Malignant Tumors
PHASE1/PHASE2
Active, not recruiting
250 participants
Started: Jan 22, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05159765
Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial
NA
Active, not recruiting
144 participants
Started: Jan 22, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
8 locations
NCT05128123
Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF
N/A
Active, not recruiting
1,600 participants
Started: Jan 21, 2022 · Completed: Dec 31, 2026
1 condition
5 sponsors
1 location
NCT05309668
Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN
PHASE1/PHASE2
Active, not recruiting
36 participants
Started: Jan 21, 2022 · Completed: Apr 28, 2028
1 condition
2 sponsors
16 locations
NCT05182866
ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer
PHASE2
Active, not recruiting
9 participants
Started: Jan 21, 2022 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT04896476
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
NA
Active, not recruiting
20 participants
Started: Jan 21, 2022 · Completed: Jun 6, 2025
2 conditions
2 sponsors
4 locations
NCT05118776
Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
PHASE3
Active, not recruiting
136 participants
Started: Jan 21, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05067790
A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)
PHASE3
Active, not recruiting
45 participants
Started: Jan 21, 2022 · Completed: Jun 14, 2027
1 condition
1 sponsor
44 locations
NCT04900506
Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach
NA
Active, not recruiting
210 participants
Started: Jan 21, 2022 · Completed: Oct 1, 2025
4 conditions
2 sponsors
2 locations
NCT05840809
Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs
N/A
Active, not recruiting
20 participants
Started: Jan 20, 2022 · Completed: Jan 29, 2026
3 conditions
2 sponsors
1 location
NCT05149326
KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.
PHASE3
Active, not recruiting
408 participants
Started: Jan 20, 2022 · Completed: Aug 30, 2024
1 condition
1 sponsor
65 locations
NCT04594980
Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
NA
Active, not recruiting
96 participants
Started: Jan 20, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT05193617
Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2
Active, not recruiting
104 participants
Started: Jan 20, 2022 · Completed: Jan 1, 2027
1 condition
1 sponsor
1 location
NCT05227287
ADH1 and ADH2 Disease Monitoring Study (DMS)
N/A
Active, not recruiting
95 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
27 locations
NCT05159440
First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer
PHASE1
Active, not recruiting
70 participants
Started: Jan 20, 2022 · Completed: Dec 15, 2025
4 conditions
2 sponsors
8 locations
NCT05089916
Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study
PHASE2
Active, not recruiting
40 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT04878627
Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
EARLY_PHASE1
Active, not recruiting
40 participants
Started: Jan 20, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05229874
Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy
PHASE2
Active, not recruiting
96 participants
Started: Jan 20, 2022 · Completed: Jan 20, 2025
1 condition
1 sponsor
1 location
NCT05229835
Effect of Time-restricted Eating and Endurance Training on Markers of the Health of Women and Men
NA
Active, not recruiting
300 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2027
5 conditions
1 sponsor
1 location
NCT05011188
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
PHASE1/PHASE2
Active, not recruiting
44 participants
Started: Jan 19, 2022 · Completed: Jul 31, 2027
2 conditions
3 sponsors
1 location
NCT05308459
Data Health VET - Data-driven Health Promotion at Vocational Education and Training Schools
NA
Active, not recruiting
1,370 participants
Started: Jan 19, 2022 · Completed: Jun 30, 2025
6 conditions
3 sponsors
2 locations
NCT05267912
Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
NA
Active, not recruiting
61 participants
Started: Jan 19, 2022 · Completed: Jan 18, 2028
1 condition
1 sponsor
1 location
NCT04482244
RCT of CBD for Anxiety in Advanced Breast Cancer
PHASE2
Active, not recruiting
60 participants
Started: Jan 19, 2022 · Completed: Dec 1, 2026
3 conditions
2 sponsors
1 location
NCT04967170
A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Jan 19, 2022 · Completed: Feb 2, 2026
1 condition
1 sponsor
1 location
NCT05443711
Sarcopenic Obesity as a Risk of Premature Aging
N/A
Active, not recruiting
75 participants
Started: Jan 19, 2022 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT05069051
Belimumab in Patients with Chronic Lymphocytic Leukemia
PHASE2
Active, not recruiting
120 participants
Started: Jan 19, 2022 · Completed: Jul 14, 2027
1 condition
2 sponsors
1 location
NCT05084053
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
PHASE3
Active, not recruiting
26 participants
Started: Jan 19, 2022 · Completed: Oct 31, 2025
2 conditions
1 sponsor
23 locations
NCT05344599
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
N/A
Active, not recruiting
70 participants
Started: Jan 19, 2022 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT05166265
Clinical Investigation Study of Safety and Performance of the Sentio System.
NA
Active, not recruiting
51 participants
Started: Jan 19, 2022 · Completed: Nov 30, 2025
3 conditions
1 sponsor
6 locations
NCT05197049
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
PHASE3
Active, not recruiting
350 participants
Started: Jan 19, 2022 · Completed: Oct 30, 2028
1 condition
1 sponsor
344 locations
NCT05107310
The Spinal Navigation Trial - Surgical Navigation or Free Hand Technique in Spine Surgery
NA
Active, not recruiting
62 participants
Started: Jan 18, 2022 · Completed: Jun 30, 2029
2 conditions
3 sponsors
1 location
NCT05215470
CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
PHASE2
Active, not recruiting
100 participants
Started: Jan 18, 2022 · Completed: Nov 30, 2026
1 condition
3 sponsors
1 location
NCT05200923
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
NA
Active, not recruiting
300 participants
Started: Jan 18, 2022 · Completed: Dec 18, 2026
3 conditions
1 sponsor
6 locations
NCT04706715
LAG3 PET Imaging in Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
41 participants
Started: Jan 18, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05470595
A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
PHASE2
Active, not recruiting
67 participants
Started: Jan 18, 2022 · Completed: Jan 31, 2029
1 condition
2 sponsors
15 locations
NCT05189197
A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double Expression
PHASE2
Active, not recruiting
41 participants
Started: Jan 18, 2022 · Completed: Jan 31, 2026
1 condition
4 sponsors
1 location
NCT05135052
Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.
NA
Active, not recruiting
210 participants
Started: Jan 17, 2022 · Completed: May 15, 2027
1 condition
1 sponsor
7 locations
NCT05153317
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older
PHASE3
Active, not recruiting
71 participants
Started: Jan 17, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
22 locations
NCT05197426
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
PHASE2
Active, not recruiting
19 participants
Started: Jan 17, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
31 locations
NCT05216276
Robotic vs. Conventional Minimal-invasive Inguinal Hernia Repair
NA
Active, not recruiting
182 participants
Started: Jan 17, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT04283227
OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)
PHASE3
Active, not recruiting
6 participants
Started: Jan 17, 2022 · Completed: Mar 31, 2031
2 conditions
2 sponsors
1 location
NCT05198609
Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC with Portal Vein Invasion: a Randomized Trial
PHASE3
Active, not recruiting
214 participants
Started: Jan 17, 2022 · Completed: Jan 1, 2026
1 condition
5 sponsors
1 location
NCT04776278
Behavioral Economic and Wellness-based Approaches for Reducing Alcohol Use and Consequences Among Emerging Adults
NA
Active, not recruiting
525 participants
Started: Jan 17, 2022 · Completed: May 1, 2026
1 condition
1 sponsor
1 location
NCT05926934
The Effectiveness of 3 Orthodontic Fixed Retention Schemes on Post-treatment Stability and Gingival Recession
NA
Active, not recruiting
90 participants
Started: Jan 16, 2022 · Completed: Nov 30, 2025
2 conditions
1 sponsor
1 location
NCT05434754
Keeping in Touch (KiT) With Youth as They Transition to Adult Type 1 Diabetes Care
NA
Active, not recruiting
234 participants
Started: Jan 16, 2022 · Completed: Sep 30, 2025
1 condition
3 sponsors
6 locations
NCT05121194
Evaluation of Virtual CBTm for Public Safety Personnel
NA
Active, not recruiting
168 participants
Started: Jan 15, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT06143644
Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence
N/A
Active, not recruiting
220 participants
Started: Jan 15, 2022 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT05007015
Transanal Irrigation for the Management of LARS
NA
Active, not recruiting
66 participants
Started: Jan 15, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
2 locations
NCT05176548
Registry of Patients with Suspected Amyloidosis in Heart Failure
N/A
Active, not recruiting
450 participants
Started: Jan 15, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
198
199
200
201
202
203
204
More pages
431
Next